Sign inGet started

Exter Neil

Insider CIK 1620014 · CTMX Director · RVMD Director · RYTM Director · DBTX Director, 10% owner · PLRX Director · MAZE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MAZE Maze Therapeutics, Inc. A Award deriv2025-09-222025-09-2418,000— $018,000SEC↗
MAZE Maze Therapeutics, Inc. A Award deriv2025-08-172025-08-1916,000— $016,000SEC↗
DBTX Decibel Therapeutics, Inc. A Award deriv2022-06-172022-06-2110,000— $010,000SEC↗
RVMD Revolution Medicines, Inc. A Award deriv2022-06-162022-06-1718,400— $018,400SEC↗
PLRX PLIANT THERAPEUTICS, INC. A Award deriv2022-06-162022-06-2115,000— $015,000SEC↗
RVMD Revolution Medicines, Inc. A Award2022-06-162022-06-175,200— $028,815SEC↗
RVMD Revolution Medicines, Inc. S Sale2022-06-082022-06-100— $00SEC↗
PLRX PLIANT THERAPEUTICS, INC. A Award deriv2021-06-292021-06-3013,286— $013,286SEC↗
RVMD Revolution Medicines, Inc. A Award deriv2021-06-222021-06-2412,659— $012,659SEC↗
RVMD Revolution Medicines, Inc. A Award2021-06-222021-06-243,617— $023,615SEC↗
RVMD Revolution Medicines, Inc. S Sale2021-06-042021-06-070— $00SEC↗
RVMD Revolution Medicines, Inc. S Sale2021-06-032021-06-070— $00SEC↗
RVMD Revolution Medicines, Inc. S Sale2021-05-262021-05-270— $00SEC↗
RVMD Revolution Medicines, Inc. S Sale2021-05-252021-05-270— $00SEC↗
RVMD Revolution Medicines, Inc. J Other2021-02-242021-02-260— $00SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion deriv2021-02-172021-02-19289,603— $00SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion deriv2021-02-172021-02-191,250,000— $00SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion deriv2021-02-172021-02-1945,638,882— $00SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion2021-02-172021-02-1954,642— $03,139,685SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion2021-02-172021-02-1998,929— $03,085,043SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion2021-02-172021-02-192,938,945— $02,986,114SEC↗
DBTX Decibel Therapeutics, Inc. A Award deriv2021-02-112021-02-1620,000— $020,000SEC↗
RVMD Revolution Medicines, Inc. J Other2020-12-022020-12-040— $00SEC↗
RVMD Revolution Medicines, Inc. J Other2020-09-092020-09-110— $00SEC↗
PLRX PLIANT THERAPEUTICS, INC. C Conversion deriv2020-06-052020-06-090— $00SEC↗
PLRX PLIANT THERAPEUTICS, INC. C Conversion2020-06-052020-06-090— $00SEC↗
PLRX PLIANT THERAPEUTICS, INC. A Award deriv2020-03-312020-06-0926,573— $026,573SEC↗
RVMD Revolution Medicines, Inc. C Conversion deriv2020-02-182020-02-200— $00SEC↗
RVMD Revolution Medicines, Inc. C Conversion deriv2020-02-182020-02-200— $00SEC↗
RVMD Revolution Medicines, Inc. C Conversion deriv2020-02-182020-02-200— $00SEC↗
RVMD Revolution Medicines, Inc. C Conversion2020-02-182020-02-200— $00SEC↗
RVMD Revolution Medicines, Inc. A Award deriv2020-02-122020-02-1436,168— $036,168SEC↗
RYTM RHYTHM PHARMACEUTICALS, IN A Award deriv2018-06-062018-06-0810,000— $010,000SEC↗
RYTM RHYTHM PHARMACEUTICALS, IN C Conversion deriv2017-10-102017-10-120— $00SEC↗
RYTM RHYTHM PHARMACEUTICALS, IN C Conversion deriv2017-10-102017-10-120— $00SEC↗
RYTM RHYTHM PHARMACEUTICALS, IN C Conversion2017-10-102017-10-120— $00SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2017-06-202017-06-2214,000— $014,000SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2017-03-272017-03-270— $00SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2017-03-232017-03-270— $00SEC↗
CTMX CytomX Therapeutics, Inc. J Other2016-11-072016-11-090— $00SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2016-06-102016-06-1414,000— $014,000SEC↗